Detail akcie Takeda Pharm online

Business Summary: Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research and development, manufacture, sale and licensing of pharmaceuticals. The Company focuses on the main business areas of gastrointestinal diseases, rare diseases, plasma derivatives (immune diseases), oncology (cancer), and neuroscience (neuropsychiatric diseases). The Company focuses on three research and development areas: innovative biopharmaceuticals with the focus on gastrointestinal and inflammatory diseases, neuroscience, and oncology, plus plasma derivatives and vaccines. Most of the pharmaceuticals treat rare diseases in the focus disease areas and the plasma derivatives area. The Company operates in Japan, the United States, Europe, and China.
Financial Summary: BRIEF: For the nine months ended 31 December 2025, Takeda Pharmaceutical Co Ltd revenues decreased 3% to Y3.411T. Net income increased 2% to Y216.08B. Revenues reflect Gastrointestinal diseases segment decrease of 29% to Y739.3B, Plasma derivatives segment decrease of 32% to Y529.6B, United States segment decrease of 39% to Y1.127T, Europe And Canada (Country) segment decrease of 28% to Y570.3B.